Ardelyx stocktwits

Through extensive research, SmartAsset compiled its review of Brandywine Global Investment Management. We provide an in-depth look at the firm featuring its fees, services, investm...

Ardelyx: Strong Execution, Fairly Valued: May 7: Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference: May 6 (ARDX) - Analyzing Ardelyx's Short Interest: May 4: Ardelyx, Inc. (NASDAQ:ARDX) Q1 2024 …About Ardelyx, Inc. Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs.

Did you know?

Ardelyx (NASDAQ:ARDX) Trading Down 3.7%. Ardelyx, Inc. (NASDAQ:ARDX - Get Free Report) insider Robert Ora Felsch sold 207,988 shares of Ardelyx stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $8.81, for a total transaction of $1,832,374.28. Following the transaction, the insider now owns 95,947 shares of ...395 subscribers in the ARDELYX community. The selective sodium hydrogen exchanger 3 (NHE3) inhibitor Tenapanor is being developed by Ardelyx Inc for…View the latest Ardelyx Inc. (ARDX) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Ardelyx, Inc. (Nasdaq: ARDX) announced the resignation of Dr. Geoffrey Block from the Board of Directors after nearly five years of service. Dr. Block is the Associate Chief Medical Director and Senior Vice President of Clinical Research and Medical Affairs at U.S. Renal Care. The company expressed gratitude for Dr. Block's contributions and highlighted his role in Ardelyx's evolution from a ...We would like to show you a description here but the site won’t allow us.Ardelyx (ARDX) delivered earnings and revenue surprises of 33.33% and 40.61%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?Ardelyx announces upcoming data presentations for tenapanor for hyperphosphatemia at the American Society of Nephrology Kidney Week 2023

Track Hub Cyber Security Ltd (HUBC) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors3 days ago · Rhea-AI Summary. Ardelyx, Inc. (Nasdaq: ARDX) reported $45.6 million in Q1 product-related revenue, with $28.4 million from IBSRELA and $15.2 million from XPHOZAH. The company ended Q1 with around $203 million in cash and investments. Ardelyx saw significant growth in net product sales revenue for both IBSRELA and XPHOZAH, with plans to expand ...Ardelyx ( NASDAQ: ARDX) is scheduled to announce Q1 earnings results on Wednesday, May 3rd, after market close. The consensus EPS Estimate is -$0.10 and the consensus Revenue Estimate is $10.41M ...…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Track C4 Therapeutics Inc (CCCC) Stock Price, Quote, late. Possible cause: Track reAlpha Tech Corp. (AIRE) Stock Pri...

Ardelyx, Inc. Reports Employment Inducement Grants. WALTHAM, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that on May 6, …View the latest Ardelyx Inc. (ARDX) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Discover Ardelyx Inc (ARDX) market and community sentiment, movement in message volume, participation score and buzz level in the Stocktwits communityARDX. Net Product Sales Revenue: IBSRELA generated $80.1 million in 2023, with Q4 showing a 26% increase over Q3. 2024 Revenue Forecast: Ardelyx projects IBSRELA sales to reach between $140.0 to ...Ardelyx, Inc. Reports Employment Inducement Grants. WALTHAM, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that on May 6, …

sachertorte ingredients crossword clue Stock analysis for Ardelyx Inc (ARDX:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Per-Share Earnings, Actuals and Estimates. View the latest Nkarta Inc. (NKTX) stock price, news, historical charts, analyst ratings and financial information from WSJ. samuels funeral home llc of manningpredator 3500 generator overload problem Dear Lifehacker, culvers flavor of the day marshfield wi A high-level overview of Ardelyx, Inc. (ARDX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. jason gutterman accidentashton altieripopshelf frankfort photos At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Based on the most recent data, ARDX has returned 44.7% so far this year. Meanwhile, the Medical sector has returned an average of 5.3% on a year-to-date basis. This means that Ardelyx is ... accident on 301 starke fl today Q1 net loss was $26.8 million, but Ardelyx raised $51.9 million through sales of their common stock at an average price of about $3.35, leaving $130.4 million in total cash and investments as of ... stfc critical damage crewpo box 7251 sioux falls sd 57117moreno valley street sweeper Get the latest Ardelyx, Inc. ARDX stock quote, price, forecast and news from CNN, the trusted source for market insights and analysis.Nachrichten zur ARDELYX Aktie - schnell & kompetent - Aktuelle TOP-Meldung: Ardelyx: Quartalsergebnisse zum jüngsten Jahresviertel